ResApp Health Limited

CHIA:RAP Stock Report

Market Cap: AU$176.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ResApp Health Management

Management criteria checks 4/4

Key information

Tony Keating

Chief executive officer

AU$318.8k

Total compensation

CEO salary percentage80.22%
CEO tenure7.2yrs
CEO ownership1.2%
Management average tenure4.4yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tony Keating's remuneration changed compared to ResApp Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022AU$319kAU$256k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$7m

Jun 30 2021AU$358kAU$256k

-AU$7m

Mar 31 2021n/an/a

-AU$7m

Dec 31 2020n/an/a

-AU$8m

Sep 30 2020n/an/a

-AU$8m

Jun 30 2020AU$449kAU$256k

-AU$8m

Mar 31 2020n/an/a

-AU$7m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$290kAU$256k

-AU$5m

Mar 31 2019n/an/a

-AU$6m

Dec 31 2018n/an/a

-AU$7m

Sep 30 2018n/an/a

-AU$7m

Jun 30 2018AU$296kAU$256k

-AU$7m

Mar 31 2018n/an/a

-AU$6m

Dec 31 2017n/an/a

-AU$6m

Sep 30 2017n/an/a

-AU$8m

Jun 30 2017AU$1mAU$256k

-AU$10m

Mar 31 2017n/an/a

-AU$10m

Dec 31 2016n/an/a

-AU$9m

Sep 30 2016n/an/a

-AU$6m

Jun 30 2016AU$537kAU$189k

-AU$3m

Compensation vs Market: Tony's total compensation ($USD214.17K) is about average for companies of similar size in the Australian market ($USD283.12K).

Compensation vs Earnings: Tony's compensation has been consistent with company performance over the past year.

CEO

Tony Keating

7.2yrs
Tenure
AU$318,770
Compensation

Dr. Anthony James Keating, also known as Tony, has been Chief Executive Officer and Managing Director of ResApp Health Limited since July 2, 2015. Dr. Keating served as a Director of Commercial Engagement...

Leadership Team

NamePositionTenureCompensationOwnership
Anthony Keating
CEO, MD & Director7.2yrsAU$318.77k1.19%
A$ 2.1m
Brian Leedman
Executive Director of Corporate Affairs & Executive Director1.3yrsAU$200.07k0.29%
A$ 512.9k
Al Lunar
Vice President of Finance1.7yrsno datano data
Scott Savage
Vice President of Technology & Productno datano datano data
Nicki Farley
Company Secretary9.8yrsno datano data
Clas Källander
Founder and Director of R&D of Cavidi ABno dataAU$108.72kno data
Mike Connell
VP of Commercialno datano datano data
Paul Porter
Scientific Advisorno datano datano data
4.4yrs
Average Tenure

Experienced Management: RAP's management team is considered experienced (4.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Anthony Keating
CEO, MD & Director7.2yrsAU$318.77k1.19%
A$ 2.1m
Brian Leedman
Executive Director of Corporate Affairs & Executive Director1.3yrsAU$200.07k0.29%
A$ 512.9k
Paul Porter
Scientific Advisorno datano datano data
Michael Stein
Non-Executive Director2.4yrsAU$55.00kno data
Roger Aston
Non-Executive Chairman7.2yrsAU$90.00k0.034%
A$ 59.4k
Joseph Kvedar
Member of Industry Advisory Board3.3yrsno datano data
Christopher Ntoumenopoulos
Non-Executive Director7.7yrsAU$55.00k0.058%
A$ 102.5k
Naomi Fried
Member of Industry Advisory Board3.3yrsno datano data
Philip Currie
Member of Scientific Advisory Board5.1yrsno datano data
Scott Claxton
Member of Scientific Advisory Board3.7yrsno datano data
Elizabeth Talbot
Member of Scientific Advisory Boardless than a yearno datano data
Catherine Bennett
Member of Scientific Advisory Boardless than a yearno datano data
3.3yrs
Average Tenure
58yo
Average Age

Experienced Board: RAP's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/09/16 04:34
End of Day Share Price 2022/09/15 00:00
Earnings2022/06/30
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ResApp Health Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott PowerMorgans Financial Limited